A detailed history of Louisiana State Employees Retirement System transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 35,100 shares of ARWR stock, worth $660,582. This represents 0.02% of its overall portfolio holdings.

Number of Shares
35,100
Previous 35,700 1.68%
Holding current value
$660,582
Previous $1.02 Million 10.68%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$21.87 - $28.24 $13,122 - $16,944
-600 Reduced 1.68%
35,100 $912,000
Q1 2024

Apr 23, 2024

BUY
$27.21 - $39.48 $152,376 - $221,087
5,600 Added 18.6%
35,700 $1.02 Million
Q4 2023

Jan 29, 2024

SELL
$21.2 - $31.03 $6,360 - $9,309
-300 Reduced 0.99%
30,100 $921,000
Q3 2023

Oct 17, 2023

SELL
$26.2 - $36.08 $20,960 - $28,864
-800 Reduced 2.56%
30,400 $816,000
Q2 2023

Jul 18, 2023

BUY
$25.16 - $41.38 $62,900 - $103,450
2,500 Added 8.71%
31,200 $1.11 Million
Q1 2023

Apr 19, 2023

BUY
$23.68 - $38.51 $9,472 - $15,404
400 Added 1.41%
28,700 $728,000
Q4 2022

Jan 24, 2023

BUY
$28.0 - $40.56 $2,800 - $4,056
100 Added 0.35%
28,300 $1.15 Million
Q3 2022

Oct 19, 2022

BUY
$29.63 - $48.31 $11,852 - $19,324
400 Added 1.44%
28,200 $932,000
Q2 2022

Jul 20, 2022

BUY
$27.79 - $50.61 $5,558 - $10,122
200 Added 0.72%
27,800 $1.19 Million
Q1 2022

Apr 22, 2022

BUY
$39.62 - $69.97 $31,695 - $55,976
800 Added 2.99%
27,600 $1.26 Million
Q4 2021

Jan 14, 2022

BUY
$58.09 - $82.51 $11,618 - $16,502
200 Added 0.75%
26,800 $1.78 Million
Q3 2021

Oct 12, 2021

SELL
$58.38 - $84.96 $23,352 - $33,984
-400 Reduced 1.48%
26,600 $1.66 Million
Q1 2021

Apr 14, 2021

BUY
$61.35 - $90.47 $79,755 - $117,611
1,300 Added 5.06%
27,000 $1.79 Million
Q4 2020

Jan 11, 2021

BUY
$43.82 - $85.37 $8,764 - $17,074
200 Added 0.78%
25,700 $1.97 Million
Q3 2020

Oct 19, 2020

BUY
$33.21 - $51.27 $3,321 - $5,127
100 Added 0.39%
25,500 $1.1 Million
Q2 2020

Jul 13, 2020

BUY
$26.12 - $43.27 $31,344 - $51,924
1,200 Added 4.96%
25,400 $1.1 Million
Q4 2019

Jan 17, 2020

SELL
$28.14 - $73.01 $309,540 - $803,110
-11,000 Reduced 31.25%
24,200 $1.54 Million
Q3 2019

Oct 24, 2019

SELL
$26.26 - $34.86 $2,626 - $3,486
-100 Reduced 0.28%
35,200 $992,000
Q2 2019

Jul 15, 2019

BUY
$17.43 - $28.82 $615,279 - $1.02 Million
35,300 New
35,300 $958,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.99B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.